
Gleways M 2mg/500mg Tablet SR
Marketer
Rowlinges Life Science
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Gleways M 2mg/500mg Tablet SR
Diabetic patients with type 2 mellitus may be prescribed Glucowin SR tablets (2mg/500mg), a dual-action anti-diabetic medication. This formulation regulates blood glucose by combining two active ingredients. Always ingest this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your individual blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, risking complications including kidney failure, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan that incorporates a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by symptoms like sweating, lightheadedness, headache, and trembling. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects comprise altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated for those with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women must consult their physician prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.
Primary Ingredients of Gleways M 2mg/500mg Tablet SR
No text provided to rephrase.
Uses of Gleways M 2mg/500mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Gleways M 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. Gleways M 2mg/500mg Sustained-Release Tablets should be taken with meals.
Common Side effects of Gleways M 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Gleways M 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gleways M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Gleways M 2mg/500mg Tablet SR works:
Gleways M 2mg/500mg Extended-Release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Gleways M 2mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Gleways M 2mg/500mg SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Gleways M tablets (2mg/500mg) are contraindicated during lactation due to the potential for infant harm from the medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gleways M 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Gleways M 2mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Exercise caution when administering Gleways M 2mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Gleways M 2mg/500mg SR tablets at a reduced dosage; its use is contraindicated in cases of severe liver disease.
What if you forget to take Gleways M 2mg/500mg Tablet SR :
Should you forget a Gleways M 2mg/500mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gleways M 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
